Search
Foropafant
go.drugbank.com/drugs/DB21304ExperimentalForopafant is a small molecule drug. The usage of the INN stem '-pafant' in the name indicates that Foropafant is a platelet-activating factor antagonist.
Cloxacepride
go.drugbank.com/drugs/DB21428ExperimentalCloxacepride is a small molecule drug. The usage of the INN stem '-pride' in the name indicates that Cloxacepride is a sulpiride derivative and analogue.
Bofutrelvir
go.drugbank.com/drugs/DB21501ExperimentalBofutrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Bofutrelvir is a antiviral 3CL protease inhibitor.
Ulecaciclib
go.drugbank.com/drugs/DB21595ExperimentalUlecaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Ulecaciclib is a cyclin dependant kinase inhibitor.
Eciruciclib
go.drugbank.com/drugs/DB21597ExperimentalEciruciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Eciruciclib is a cyclin dependant kinase inhibitor.
Zevotrelvir
go.drugbank.com/drugs/DB21638ExperimentalZevotrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Zevotrelvir is a antiviral 3CL protease inhibitor.
Orenasitecan
go.drugbank.com/drugs/DB21718ExperimentalOrenasitecan is a small molecule drug. The usage of the INN stem '-tecan' in the name indicates that Orenasitecan is a antineoplastic, topoisomerase I inhibitor.
Mocaciclib
go.drugbank.com/drugs/DB21730ExperimentalMocaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Mocaciclib is a cyclin dependant kinase inhibitor.
Monlunabant
go.drugbank.com/drugs/DB21537InvestigationalMonlunabant is under investigation in clinical trial NCT06542536 (A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight … Monlunabant is a small molecule drug. The usage of the INN stem '-nabant' in the name indicates that Monlunabant is a cannabinoid receptor antagonist.
Nanoparticle Epirubicin
go.drugbank.com/drugs/DB16248InvestigationalNanoparticle Epirubicin is under investigation in clinical trial NCT03168061 (Dose-escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma). … It is a novel [epirubicin] drug-conjugated polymeric micelle.